Impact of recurrent dehydration with mild periodic water restriction on blood pressure and renal function in male spontaneously hypertensive rats
Experimental Physiology · 2026-07 · 111 (7) · 3398-3411
DOI: 10.1113/ep092812 ↗At a glance
Journal article in Experimental Physiology, published online on 2026-05-13. Written by Katrina M Mirabito Colafella and 7 co-authors. Institution: Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, Victoria, Australia. Major MEDLINE topics: Dehydration, Blood Pressure, Kidney, Hypertension. 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHMRC, National Health and Medical Research Council.
Abstract (original language)
The kidneys regulate fluid balance but are susceptible to adverse effects of inadequate hydration. Epidemiological studies have linked low water intake to renal dysfunction and chronic kidney disease. Previously we showed that restricting water intake to a single 2‐h period daily for 4 weeks promotes hypertension as well as renal inflammation, fibrosis and dysfunction in male spontaneously hypertensive rats (SHR). Building on these findings, the aim of the present study was to determine whether a milder, more intermittent dehydration protocol (two 1‐h periods of water access per weekday plus free access on weekends for 8 weeks) would affect renal function, renal fibrosis and inflammation, and blood pressure in the same rat model. We hypothesised that this protocol would maintain renal function, limit renal fibrosis and inflammation, and avoid further exacerbation of hypertension in male SHR. Our findings showed that the mild water restriction protocol resulted in cyclic changes in urine osmolarity, indicating periods of dehydration and rehydration. However, it did not exacerbate hypertension, accelerate renal dysfunction or increase proinflammatory processes in the kidneys. These results suggest that mild recurrent dehydration does not produce the same adverse effects observed under stricter water restriction and that the impact of recurrent dehydration on chronic kidney disease progression may depend on the severity and pattern of water restriction.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, Victoria, Australia.
- Centre for Cardiovascular Biology and Disease Research (CCBDR), La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria, Australia.
- Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Victoria, Australia.
ORCID profiles: Lucinda M Hilliard Krause
Funding
- NHMRC
- National Health and Medical Research Council
Cite
APA
Mirabito Colafella, K. M., Nguyen, P. N. H., McArdle, Z., Fong, D., Kwok, E., Denton, K. M., Vinh, A., & Krause, L. M. H. (2026). Impact of recurrent dehydration with mild periodic water restriction on blood pressure and renal function in male spontaneously hypertensive rats. Experimental Physiology, 111(7), 3398-3411. https://doi.org/10.1113/ep092812
Vancouver
Mirabito Colafella KM, Nguyen PNH, McArdle Z, Fong D, Kwok E, Denton KM, et al. Impact of recurrent dehydration with mild periodic water restriction on blood pressure and renal function in male spontaneously hypertensive rats. Experimental Physiology. 2026;111(7):3398-3411. doi:10.1113/ep092812
BibTeX
@article{MirabitoColafella2026,
author = {Mirabito Colafella, Katrina M and Nguyen, Peter N H and McArdle, Zoe and Fong, Debra and Kwok, Edmund and Denton, Kate M and Vinh, Antony and Krause, Lucinda M Hilliard},
title = {Impact of recurrent dehydration with mild periodic water restriction on blood pressure and renal function in male spontaneously hypertensive rats},
journal = {Experimental Physiology},
year = {2026},
volume = {111},
number = {7},
pages = {3398--3411},
doi = {10.1113/ep092812}
}
EUVIMED